Éric Vivier
Impact in
- Immunology top 0.01%
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune cells in cancer
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 380
- Immune Cell Function and Interaction 259
- T-cell and B-cell Immunology 52
- IL-33, ST2, and ILC Pathways 48
- Immunotherapy and Immune Responses 16
- Immune Response and Inflammation 15
- Oncology 22
- Cancer Immunotherapy and Biomarkers 17
- Co-authors
- Sophie Ugolini (50 shared papers)Thierry Walzer (27 shared papers)Elena Tomasello (34 shared papers)Myriam Baratin (13 shared papers)Frédéric Vely (47 shared papers)Alessandro Moretta (16 shared papers)Laura Chiossone (13 shared papers)Émilie Narni-Mancinelli (28 shared papers)
- Journals
- The Journal of Immunology (38 papers)European Journal of Immunology (25 papers)Nature Immunology (25 papers)The Journal of Experimental Medicine (24 papers)Blood (20 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Éric Vivier
421 papers receiving 51.6k citations
Éric Vivier's Hit Papers
Peers
Comparison fields: 5 of 159
- Immunology 34.5k
- Oncology 5.9k
- Virology 431
- Hematology 1.3k
- Physiology 381
Countries citing papers authored by Éric Vivier
This map shows the geographic impact of Éric Vivier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Vivier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Vivier more than expected).
Fields of papers citing papers by Éric Vivier
This network shows the impact of papers produced by Éric Vivier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Vivier. The network helps show where Éric Vivier may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Vivier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 431 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Functions of natural killer cells Hit paper breakdown → | 2008 | 3230 |
| 2 | Innate or Adaptive Immunity? The Example of Natural Killer Cells Hit paper breakdown → | 2011 | 2234 |
| 3 | Innate lymphoid cells — a proposal for uniform nomenclature Hit paper breakdown → | 2013 | 2002 |
| 4 | The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide Hit paper breakdown → | 2013 | 1741 |
| 5 | Innate Lymphoid Cells: 10 Years On Hit paper breakdown → | 2018 | 1730 |
| 6 | Human NK Cell Education by Inhibitory Receptors for MHC Class I Hit paper breakdown → | 2006 | 1013 |
| 7 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Hit paper breakdown → | 2018 | 996 |
| 8 | TLR3 Deficiency in Patients with Herpes Simplex Encephalitis Hit paper breakdown → | 2007 | 967 |
| 9 | Natural killer cells and other innate lymphoid cells in cancer Hit paper breakdown → | 2018 | 830 |
| 10 | Harnessing innate immunity in cancer therapy Hit paper breakdown → | 2019 | 808 |
| 11 | 2005 | 795 | |
| 12 | Targeting natural killer cells and natural killer T cells in cancer Hit paper breakdown → | 2012 | 691 |
| 13 | 2009 | 654 | |
| 14 | 2004 | 602 | |
| 15 | 2009 | 576 | |
| 16 | Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells Hit paper breakdown → | 2017 | 556 |
| 17 | 2005 | 506 | |
| 18 | 2014 | 503 | |
| 19 | 2008 | 489 | |
| 20 | 2007 | 442 |
About Éric Vivier
Éric Vivier is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Hematology, having authored 431 papers that have together received 52.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (259 papers), T-cell and B-cell Immunology (52 papers), IL-33, ST2, and ILC Pathways (48 papers), Cancer Immunotherapy and Biomarkers (17 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Immunotherapy and Immune Responses (16 papers), Immune Response and Inflammation (15 papers) and Sphingolipid Metabolism and Signaling (9 papers). The work is most often cited by research in Immunology (34.5k citations), Oncology (5.9k citations), Virology (431 citations), Hematology (1.3k citations) and Physiology (381 citations). Éric Vivier has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Sophie Ugolini, Thierry Walzer, Elena Tomasello, Myriam Baratin, Frédéric Vely, Alessandro Moretta, Laura Chiossone, Émilie Narni-Mancinelli, Marc Daëron and Laurence Zitvogel. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, Nature Immunology, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.